Related Experiment Video
Updated: Feb 11, 2026

A Cost Effective and Adaptable Scratch Migration Assay
Published on: June 30, 2020
Future unrelated medical costs need to be considered in cost effectiveness analysis
Pieter van Baal1, Alec Morton2, David Meltzer3
1Erasmus School of Health Policy and Management Health Economics (HE), Erasmus University Rotterdam, Rotterdam, The Netherlands. vanbaal@eshpm.eur.nl.
Abstract:
New medical technologies that prolong life result in additional health care use in life years gained. Some of these costs in life years gained are considered to be related to the intervention while other costs are considered unrelated. Here, we argue that ignoring these so-called future medical costs in cost effectiveness analysis is contrary to common sense, results in lost health and fails to inform decision makers for whom cost effectiveness is supposed to serve.
Related Concept Videos
Inhaled Medications
Endocarditis III: Medical Management
Myocarditis III: Medical Management
Pericarditis III: Medical Management
Heart Failure V: Medical Management
Buffer Effectiveness
The buffer capacity is the amount of acid or base that can be added to a given volume...

